Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base-Reference-Cited by-同舟云学术

Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base

Published:2014-01-03 Issue:4 Volume:120 Page:499-506
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Colbert Lauren E.¹,Hall William A.¹,Nickleach Dana²,Switchenko Jeffrey²,Kooby David A.³⁴,Liu Yuan²,Gillespie Theresa³⁴,Lipscomb Joseph⁴⁵,Kauh John⁶,Landry Jerome C.¹

Affiliation:

1. Department of Radiation Oncology and Winship Cancer Institute; Emory University; Atlanta Georgia

2. Biostatistics and Bioinformatics Shared Resource at Winship Cancer Institute; Atlanta Georgia

3. Department of Surgery and Winship Cancer Institute; Emory University School of Medicine; Atlanta Georgia

4. Atlanta Veterans Affairs Medical Center; Atlanta Georgia

5. Rollins School of Public Health and Winship Cancer Institute; Atlanta Georgia

6. Department of Hematology and Medical Oncology and Winship Cancer Institute; Emory University; Atlanta Georgia

Funder

National Institutes of Health

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference28 articles.

1. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

2. Pancreatic cancer;Li;Lancet,2004

3. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial;Neoptolemos;Lancet,2001

4. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial;Regine;JAMA,2008

5. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas;Spitz;J Clin Oncol,1997

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ELK1 Enhances Pancreatic Cancer Progression Via LGMN and Correlates with Poor Prognosis;Frontiers in Molecular Biosciences;2021-12-13

2. Neoadjuvant therapy is associated with lower margin positivity rates after Pancreaticoduodenectomy in T1 and T2 pancreatic head cancers: An analysis of the National Cancer Database;Surgery Open Science;2021-01

3. Neoadjuvant Therapy;Advances in Surgery;2020-09

4. Predicting Positive Margins in Pancreatic Head Adenocarcinoma After Neoadjuvant Therapy: Investigating Disparities in Quality Care Using the National Cancer Database;Annals of Surgical Oncology;2020-08-27

5. P-glycoprotein associated with diabetes mellitus and survival of patients with pancreatic cancer: 8-year follow-up;Brazilian Journal of Medical and Biological Research;2020